Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;97(7):e70471.
doi: 10.1002/jmv.70471.

IgG and IgM Seroreactivity Against Natural HPV16 Infection and HLA-DRB1 and -DQB1 Polymorphism

Affiliations

IgG and IgM Seroreactivity Against Natural HPV16 Infection and HLA-DRB1 and -DQB1 Polymorphism

Letícia Boslooper Gonçalves et al. J Med Virol. 2025 Jul.

Abstract

Little is known about the factors associated with the natural humoral immune response against human papillomavirus (HPV) infection. The association between HLA-DRB1 and -DQB1 polymorphism and (1) HPV16 DNA detection, (2) naturally developed humoral immune response (IgG and IgM) against HPV16 L1 and L2 capsid proteins, and (3) type of HPV16 infection (transient or persistent) was investigated. Data from 943 women participating in the Ludwig-McGill cohort study was analyzed. HLA-DRB1 and HLA-DQB1 genotyping was done by PCR-based methods. HPV DNA was assessed every 4 months during the first year of follow-up, and HPV16 IgG and IgM antibody measurements were performed by ELISA in serum samples from the first and/or second visits. Associations were estimated by adjusted logistic regression models. HLA-DRB1*03:02 was associated with HPV16 DNA positivity (OR = 2.49, 95% CI: 1.11-5.60). HLA-DRB1*13:01 and HLA-DQB1*04:02 were associated with low levels of HPV16 IgG antibodies (OR = 0.44, 95% CI:0.23-0.87; OR = 0.10, 95% CI: 0.02-0.55, respectively). Neither IgM HPV16 antibodies nor the type of HPV16 infection (transient or persistent) were associated with HLA-DRB1 or -DQB1 variants. HLA-DRB1 and -DQB1 polymorphism might be associated with different levels of IgG against HPV16 infection, but IgM production and the type of infection seem to occur independently of these variants.

Keywords: HLA polymorphism; HPV16; IgG; IgM; antibody.

PubMed Disclaimer

Conflict of interest statement

ELF's institution has received grants from Merck in support of his investigator‐initiated studies. He has also served as an occasional advisor for companies involved with HPV vaccines (Merck, GSK) and HPV diagnostics (Roche, BD). LLV has received institutional grants from Merck to support her investigator‐initiated studies. She is also an occasional advisor and speaker of Merck, Sharp and Dohme for HPV vaccines and HPV diagnostics (Roche, BD. Qiagen, Cepheid). HT has received occasional lecture fees from Merck. The other authors reported no conflict of interest.

References

    1. Chesson H. W., Dunne E. F., Hariri S., and Markowitz L. E., “The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States,” Sexually Transmitted Diseases 41, no. 11 (2014): 660–664. - PMC - PubMed
    1. Franco E. L., Villa L. L., Sobrinho J. P., et al., “Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women From a High‐Risk Area for Cervical Cancer,” Journal of Infectious Diseases 180, no. 5 (1999): 1415–1423. - PubMed
    1. Trottier H. and Franco E. L., “The Epidemiology of Genital Human Papillomavirus Infection,” Vaccine 24 (2006): S4–S15. - PubMed
    1. International Human Papillomavirus Reference Center [Internet] . [cited 2025 Jan 26], https://www.hpvcenter.se/human_reference_clones/.
    1. Bruni L., Albero G., Serrano B., et al., “ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre),” Human Papillomavirus and Related Diseases in the World. [Internet] (2023): 1–296, www.hpvcentre.net.

MeSH terms